AC Immune (ACIU) Cash & Equivalents Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -19.04% |
| Sep 30, 2025 | -7.31% |
| Jun 30, 2025 | -49.52% |
| Mar 31, 2025 | -66.01% |
| Dec 31, 2024 | -53.21% |
| Sep 30, 2024 | 3.51% |
| Jun 30, 2024 | 147.08% |
| Mar 31, 2024 | 5.18% |
| Dec 31, 2023 | 169.90% |
| Sep 30, 2023 | -21.56% |
| Jun 30, 2023 | -58.85% |
| Mar 31, 2023 | -0.84% |
| Dec 31, 2022 | -63.23% |
| Sep 30, 2022 | 45,110.60% |
| Jun 30, 2022 | 74,650.25% |
| Mar 31, 2022 | 37,373.35% |
| Dec 31, 2021 | -49.90% |
| Sep 30, 2021 | -99.95% |
| Jun 30, 2021 | -99.94% |
| Mar 31, 2021 | -99.91% |
| Dec 31, 2020 | -9.01% |
| Sep 30, 2020 | -11.05% |
| Jun 30, 2020 | -99.91% |
| Mar 31, 2020 | -15.24% |
| Dec 31, 2019 | 24.41% |
| Dec 31, 2018 | 24.71% |
| Dec 31, 2017 | -17.18% |
| Sep 30, 2017 | 1.38% |
| Jun 30, 2017 | -1.52% |
| Dec 31, 2016 | 96.84% |
| Dec 31, 2015 | 2,154.27% |